NCT03302143

Brief Summary

Total of 48 subjects were randomly assigned to treatment groups: UT Health Science Center at San Antonio Chi Mei Medical Center, Tainan, Taiwan Patients require a maxillary non-molar extraction site that is planned to be replaced by a dental implant and crown. This includes Straumann BL SLActive: Narrow (3.3mm) \& Regular (4.1mm) Crossfit implants in all available lengths. Patients were randomly selected to receive either FDBA (test) or Autogenous bone + DBBM (control/standard) for contour augmentation.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
48

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jul 2013

Typical duration for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 30, 2013

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 15, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 15, 2016

Completed
1.4 years until next milestone

First Submitted

Initial submission to the registry

September 26, 2017

Completed
8 days until next milestone

First Posted

Study publicly available on registry

October 4, 2017

Completed
Last Updated

October 4, 2017

Status Verified

September 1, 2017

Enrollment Period

2.8 years

First QC Date

September 26, 2017

Last Update Submit

September 29, 2017

Conditions

Keywords

Dental ImplantGuided Bone RegenerationContour Augmentation

Outcome Measures

Primary Outcomes (1)

  • Facial bone thickness

    Facial bone thickness 1 year post-loading at 1, 3, and 5mm from the implant platform

    Measured at 1 year post-loading

Secondary Outcomes (5)

  • Change in facial bone thickness

    Between implant placement and 1 year post-loading

  • mPI measurement

    Measured at 6 and 12-months post-loading

  • PD measurement

    Measured at 6 and 12-months post-loading

  • mSBI measurement

    Measured at 6 and 12-months post-loading

  • KM measurement

    Measured at 6 and 12-months post-loading

Study Arms (2)

Control

ACTIVE COMPARATOR

Guided bone regeneration with Bovine Bone Mineral

Procedure: Guided bone regeneration with Bovine Bone Mineral

Experimental

EXPERIMENTAL

Guided bone regeneration with freeze dried bone allograft

Procedure: Guided bone regeneration with freeze dried bone allograft

Interventions

Guided bone regeneration with Bovine Bone Mineral

Control

Guided bone regeneration with freeze dried bone allograft

Experimental

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • The patient is 18 years or older.
  • Non-smoker or patient has smoking habit and \< 1 pack per day.
  • Ability to understand and provide informed consent before starting the study.
  • Ability and willingness to comply with all study requirements.
  • The patient, if of child-bearing potential, has a negative urine pregnancy test.
  • Adequate oral hygiene to allow for implant therapy consistent with standards of care.
  • Adequate primary stability following early implant placement protocols utilizing Straumann Bone Level implants NC 3.3mm or RC 4.1mm in diameter at all available implant lengths.
  • One or more teeth in maxilla (11,12,13,14,15,21,22,23,24,25 according to FDI) has been identified as having a hopeless prognosis requiring extraction leading to a single-tooth gap requiring implant placement as determined by clinician.
  • Implant site that has a defect and requires bone augmentation. This will be determined by measuring on the CBCT image the available space for the implant and whether or not there is enough bone width where the implant is to be placed.

You may not qualify if:

  • Patient reports current smoking habit \> 1 pack per day or tobacco chewing use.
  • History of alcoholism or drug abuse within the past 5 years.
  • Severe bruxism or clenching habits.
  • Patient has significant untreated periodontal disease (grade III or IV), caries, or clinical or radiographic signs of infection within two adjacent tooth positions of implant area.
  • History of HIV infection, Hepatitis B or C.
  • Patients with a history of systemic disease that precludes standard dental implant therapy.
  • Presence of local inflammation or mucosal diseases such as lichen planus
  • Patient history consistent with high risk for subacute bacterial endocarditis
  • Current hematological disorder or coumadin (or similar) therapy
  • Patient currently undergoing chemotherapy
  • Patient history of radiation treatment to the head or neck
  • Physical or mental handicaps that would interfere with patient's ability to exercise good oral hygiene on a regular basis
  • Pregnant or breastfeeding women

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

AnodontiaTooth Fractures

Condition Hierarchy (Ancestors)

Tooth AbnormalitiesStomatognathic System AbnormalitiesStomatognathic DiseasesTooth DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesTooth InjuriesWounds and Injuries

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: A comparative, randomized, prospective, clinical study
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 26, 2017

First Posted

October 4, 2017

Study Start

July 30, 2013

Primary Completion

May 15, 2016

Study Completion

May 15, 2016

Last Updated

October 4, 2017

Record last verified: 2017-09